IL226067A0 - An iontophoretic system for independent drug administration operated by the user - Google Patents

An iontophoretic system for independent drug administration operated by the user

Info

Publication number
IL226067A0
IL226067A0 IL226067A IL22606713A IL226067A0 IL 226067 A0 IL226067 A0 IL 226067A0 IL 226067 A IL226067 A IL 226067A IL 22606713 A IL22606713 A IL 22606713A IL 226067 A0 IL226067 A0 IL 226067A0
Authority
IL
Israel
Prior art keywords
contained
user
delivery system
drug delivery
iontophoretic drug
Prior art date
Application number
IL226067A
Other languages
English (en)
Hebrew (he)
Original Assignee
Nupathe Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nupathe Inc filed Critical Nupathe Inc
Publication of IL226067A0 publication Critical patent/IL226067A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/0404Electrodes for external use
    • A61N1/0408Use-related aspects
    • A61N1/0428Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/20Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A61N1/303Constructional details
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/325Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Electrotherapy Devices (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
IL226067A 2010-11-23 2013-04-30 An iontophoretic system for independent drug administration operated by the user IL226067A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41662310P 2010-11-23 2010-11-23
PCT/US2011/059981 WO2012071175A1 (en) 2010-11-23 2011-11-09 User-activated self-contained co-packaged iontophoretic drug delivery system

Publications (1)

Publication Number Publication Date
IL226067A0 true IL226067A0 (en) 2013-06-27

Family

ID=45044724

Family Applications (1)

Application Number Title Priority Date Filing Date
IL226067A IL226067A0 (en) 2010-11-23 2013-04-30 An iontophoretic system for independent drug administration operated by the user

Country Status (12)

Country Link
US (1) US9327114B2 (https=)
EP (1) EP2643048A1 (https=)
JP (1) JP2013543773A (https=)
CN (1) CN103228318B (https=)
AU (1) AU2011332187B2 (https=)
BR (1) BR112013012117A8 (https=)
CA (1) CA2817824A1 (https=)
EA (1) EA026254B1 (https=)
IL (1) IL226067A0 (https=)
MX (1) MX336812B (https=)
NZ (1) NZ610305A (https=)
WO (1) WO2012071175A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103228318B (zh) 2010-11-23 2016-03-23 泰华制药国际有限公司 使用者激活的自包含共封装的离子透入给药系统
US9744353B2 (en) 2012-11-14 2017-08-29 Teva Pharmaceuticals International Gmbh Detection of presence and alignment of a therapeutic agent in an iontophoretic drug delivery device
TW201431570A (zh) 2012-11-22 2014-08-16 Ucb Pharma Gmbh 用於經皮投服羅替戈汀(Rotigotine)之多天式貼片
EP3016641B1 (de) * 2013-07-03 2018-09-05 LTS Lohmann Therapie-Systeme AG Transdermales therapeutisches system mit elektronischem bauteil
EP2886153A1 (de) 2013-12-20 2015-06-24 LTS LOHMANN Therapie-Systeme AG System für die transdermale Abgabe von Wirkstoff
WO2015177209A1 (en) 2014-05-20 2015-11-26 Lts Lohmann Therapie-Systeme Ag Method for adjusting the release of active agent in a transdermal delivery system
EP3145502B1 (en) 2014-05-20 2022-07-06 LTS Lohmann Therapie-Systeme AG Transdermal delivery system containing rotigotine
US11752110B2 (en) 2014-05-20 2023-09-12 Lts Lohmann Therapie-Systeme Ag Transdermal delivery system including an interface mediator
JP2016002368A (ja) * 2014-06-18 2016-01-12 日本電信電話株式会社 経皮薬物送達システム
WO2018006069A1 (en) 2016-06-30 2018-01-04 Teva Pharmaceuticals International Gmbh Improved formulations for transdermal pharmaceutical systems
PL3788954T3 (pl) * 2019-09-06 2022-09-12 Smartmedics Sp. Z O.O. Struktura warstwowa z lokalnym zbiornikiem
FR3152229A1 (fr) * 2023-08-25 2025-02-28 Feeligreen Dispositif de traitement de la peau

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141359A (en) 1976-08-16 1979-02-27 University Of Utah Epidermal iontophoresis device
US5042975A (en) 1986-07-25 1991-08-27 Rutgers, The State University Of New Jersey Iontotherapeutic device and process and iontotherapeutic unit dose
US4917676A (en) 1986-11-20 1990-04-17 Ciba-Geigy Corporation User-activated transdermal therapeutic system
US4927408A (en) 1988-10-03 1990-05-22 Alza Corporation Electrotransport transdermal system
DE3903794A1 (de) 1989-02-09 1990-08-16 Lohmann Therapie Syst Lts Therapeutisches system zur transdermalen oder transmucosalen verabreichung von wirkstoffen und seine verwendung
US5047007A (en) 1989-12-22 1991-09-10 Medtronic, Inc. Method and apparatus for pulsed iontophoretic drug delivery
US5246418A (en) 1991-12-17 1993-09-21 Becton Dickinson And Company Iontophresis system having features for reducing skin irritation
US5499967A (en) 1992-02-27 1996-03-19 Societe Anonyme Dite: Laboratoires D'hygiene Societe Anonyme Dite: Et De Dietetique (L.H.D.) Transdermal drug delivery device with waveshape generator
FR2688106B1 (fr) 1992-02-27 1994-09-09 Lhd Lab Hygiene Dietetique Dispositif de generation d'une tension electrique de forme d'onde predeterminee, appareil ionophoretique d'administration transdermique de medicaments.
US5310404A (en) * 1992-06-01 1994-05-10 Alza Corporation Iontophoretic delivery device and method of hydrating same
FI944321L (fi) 1992-11-05 1994-11-16 Becton Dickinson Co Käyttäjäaktivoitu iontoforeettinen laite ja menetelmä sen käyttämiseksi
US5445609A (en) 1993-05-28 1995-08-29 Alza Corporation Electrotransport agent delivery device having a disposable component and a removable liner
US5458569A (en) 1993-06-08 1995-10-17 Becton Dickinson And Company Wearable iontophoresis system
US5533971A (en) 1993-09-03 1996-07-09 Alza Corporation Reduction of skin irritation during electrotransport
JPH08155041A (ja) 1994-12-05 1996-06-18 Advance Co Ltd イオントフォレシス用新規高能率電極システム
US5697896A (en) 1994-12-08 1997-12-16 Alza Corporation Electrotransport delivery device
AU695170B2 (en) 1994-12-21 1998-08-06 Theratech, Inc. Transdermal delivery system with adhesive overlay and peel seal disc
US5879322A (en) 1995-03-24 1999-03-09 Alza Corporation Self-contained transdermal drug delivery device
IE960312A1 (en) 1995-06-02 1996-12-11 Alza Corp An electrotransport delivery device with voltage boosting¹circuit
IE960375A1 (en) 1995-06-05 1996-12-11 Alza Corp Device for transdermal electrotransport delivery of fentanyl¹and sufentanil
US6881208B1 (en) 1995-06-05 2005-04-19 Joseph B. Phipps Method and device for transdermal electrotransport delivery of fentanyl and sufentanil
US5983130A (en) 1995-06-07 1999-11-09 Alza Corporation Electrotransport agent delivery method and apparatus
US6167301A (en) 1995-08-29 2000-12-26 Flower; Ronald J. Iontophoretic drug delivery device having high-efficiency DC-to-DC energy conversion circuit
EP0847775B1 (en) 1995-08-31 2004-10-27 Hisamitsu Pharmaceutical Co. Inc. Iontophoresis device and method of current control therefor
US5688232A (en) 1995-09-28 1997-11-18 Becton Dickinson And Company Iontophoretic drug delivery device having an improved controller
US5738647A (en) 1996-09-27 1998-04-14 Becton Dickinson And Company User activated iontophoretic device and method for activating same
US20010009983A1 (en) 1997-09-29 2001-07-26 Drug Delivery Technologies, Inc. Methods for implementing current delivery profiles used in an iontophoretic system
AU1997699A (en) 1997-12-16 1999-07-05 Alza Corporation Regulator with artificial load to maintain regulated delivery
EP1047475B1 (en) 1997-12-17 2007-02-21 ALZA Corporation Iontophoresis with programmed adjustment of electric current
CA2367485A1 (en) 1999-04-12 2000-10-19 Hisamitsu Pharmaceuticals Co., Inc. Device for iontophoresis
US6385488B1 (en) 1999-05-20 2002-05-07 Vyteris, Inc. Circuits for increasing the reliability of an iontophoretic system
US6377848B1 (en) 1999-08-25 2002-04-23 Vyteris, Inc. Devices activating an iontophoretic delivery device
DK1435945T3 (da) 2001-06-05 2008-12-01 Ronald Aung-Din Topisk migræne terapi
US6745071B1 (en) 2003-02-21 2004-06-01 Birch Point Medical, Inc. Iontophoretic drug delivery system
EP1893278A2 (en) 2005-06-03 2008-03-05 Trans-Dermal Patents Company, LLC Agent delivery system
WO2009006349A2 (en) * 2007-06-29 2009-01-08 Polyplus Battery Company Electrotransport devices, methods and drug electrode assemblies
CA2944660A1 (en) * 2008-12-30 2010-07-08 Teva Pharmaceuticals International Gmbh Electronic control of drug delivery system
CN103228318B (zh) 2010-11-23 2016-03-23 泰华制药国际有限公司 使用者激活的自包含共封装的离子透入给药系统

Also Published As

Publication number Publication date
EP2643048A1 (en) 2013-10-02
AU2011332187A1 (en) 2013-05-02
BR112013012117A8 (pt) 2017-10-10
MX2013005430A (es) 2013-07-05
US20130296766A1 (en) 2013-11-07
WO2012071175A1 (en) 2012-05-31
CN103228318B (zh) 2016-03-23
MX336812B (es) 2016-02-02
AU2011332187B2 (en) 2016-03-03
EA026254B1 (ru) 2017-03-31
US9327114B2 (en) 2016-05-03
BR112013012117A2 (pt) 2016-09-27
CN103228318A (zh) 2013-07-31
JP2013543773A (ja) 2013-12-09
NZ610305A (en) 2015-10-30
EA201390745A1 (ru) 2014-01-30
CA2817824A1 (en) 2012-05-31

Similar Documents

Publication Publication Date Title
IL226067A0 (en) An iontophoretic system for independent drug administration operated by the user
ZA201502352B (en) Liposomal drug delivery system
GB2491327B (en) Delayed prolonged drug delivery
PL2560624T3 (pl) Formulacja terapeutyczna do zmniejszania skutków ubocznych leku
EP2401012A4 (en) ACTIVE RELEASE SYSTEM
HUE059078T2 (hu) Glutation-alapú hatóanyagszállító rendszer
PL2396072T3 (pl) Układ do dostarczania sondy stymulacyjnej
IL279626A (en) Increasing the bioavailability of a drug in treatment with naltrexone
HUE041273T2 (hu) Gyógyászati adagoló rendszerek
ZA201309156B (en) Drug delivery system
IL227352A0 (en) A system for ocular administration of a drug
AU2013344654A1 (en) Oral transmucosal drug delivery system
IL236757A0 (en) A device for administering a drug with retention in the digestive system
EP2582396A4 (en) REMEDY FORMULATIONS WITH LONG-TERM EFFECT
GB201110632D0 (en) Drug delivery formulations
HK1190106A (en) User-activated self-contained co-packaged iontophoretic drug delivery system
GB201005639D0 (en) Drug delivery formulations
GB201018750D0 (en) Drug delivery system
GB201012047D0 (en) Pharmaceutical formulations
GB201012046D0 (en) Pharmaceutical formulations
AU2010902059A0 (en) Novel drug delivery system